For some biotechs moving on from SVB, not all traditional banks are an option

Even though companies that banked with SVB are now able to make payroll thanks to the federal government’s intervention this week, the dust hasn’t settled. Larger institutions like J.P. Morgan Chase aren’t exactly rolling out the red carpet for small and midsize life sciences companies and smaller banks are under pressure, too.